IONCLINICS / DEIONIC S.L.

IONCLINICS operates across medical devices, neurotechnology, therapeutics, and research tools, with a focus on neuromodulation and rehabilitation. Its described portfolio spans non-invasive brain stimulation, peripheral nerve stimulation, therapeutic electrolysis, and inertial training equipment. This breadth gives the company a wider modality mix than a profile limited to a single stimulation device or therapy type, while its professional training offering connects product use with practitioner education. Named products include EPTE Bipolar tDCS, YINGCHI M-100 Ultimate, FMS, and the EPTE systems. Its clearest stated distinction is the combination of invasive and non-invasive neuromodulation products with therapeutic electrolysis, rehabilitation equipment, and training. The company appears to serve healthcare professionals and patients, but the size and geographic reach of those markets are not established here.

The product portfolio does indicate activity across several related areas: EPTE Bipolar tDCS for non-invasive stimulation, YINGCHI M-100 Ultimate and FMS for magnetic stimulation, EPTE System products for therapeutic electrolysis and electrostimulation, and EPTE Inertial Concept for rehabilitation and functional exercise. Without dates for launches or adoption metrics, these products cannot be treated as evidence of recent acceleration. Overall, the visible trajectory is one of a broad, multi-modality device and training portfolio, while changes in scale, market expansion, and commercial momentum remain unclear.